Submitted by Anonymous (not verified) on 26 November 2025 - 15:26
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 13, Status: Authorised